OCT2 expression can be partially recovered using methylase inhibitors in RCC cell lines and in vivo; however, OAT1 and OAT3 expression remains absent in the presence of methylase inhibitors in vitro [7]. Here, SLC22A2 is linked to renal cell carcinoma.